Carrier Consent in Insurance Agency Sales: What Every Buyer and Seller Must Understand Before Closing

Carrier consent is the written permission each carrier requires before its agency agreement can be transferred to a new owner. If your agency has ten carrier appointments — and most P&C independents have several — each one may need to separately consent to the sale before the buyer can legally write new business or service existing policies under those appointments. It's one of the most overlooked mechanics in agency transactions, and it's capable of stalling or killing a deal that looked clean on every other dimension.

Before you sign a letter of intent, understand exactly how this works.

What Carrier Consent Actually Is

When you were first appointed with a carrier, you signed an agency agreement — a contract defining the terms under which you can sell and service that carrier's products. Buried in that agreement, almost universally, is an assignment clause.

The Independent Insurance Agents & Brokers of America (Big "I") and its affiliate IIAT have long advocated for a standard successor clause that permits an agent to "assign or transfer the agreement with the written consent of the company, with such consent not unreasonably withheld." That's the favorable version. The unfavorable version simply says the agreement cannot be assigned at all without express written approval — no "not unreasonably withheld" protection.

In practice, this means: when you sell your agency, you are not automatically transferring your carrier appointments to the buyer. You are asking each carrier to agree to a change in who holds those appointments. The carrier can evaluate the request and, depending on your agreement, can approve, deny, or impose conditions.

Why Most Sellers Underestimate This Step

The deal math looks straightforward: your agency generates $400,000 in annual commission revenue across a book of 450 clients. A buyer offers 2.8× revenue. You sign an LOI and start due diligence. What could go wrong?

What goes wrong is this: five of your eight carrier appointments include assignment clauses, and three of those carriers need time to review the buyer's licensing, financial profile, and production history before approving. One carrier has a minimum production requirement the buyer doesn't currently meet. Another is in the middle of an underwriting review that delayed its approval process to several months. The close date passes, the deal restructures, the buyer gets nervous, and a deal that was financially clean dies on a contractual technicality.

The OPTIS Partners 2025 year-end M&A analysis counted 695 insurance agency transactions in 2025, down from 787 the prior year. Of those, P&C agencies represented 455 deals — 66 percent of total transaction volume. In every single one of those deals, carrier consent was a variable on the table. The transactions that close cleanly are the ones where the parties identified the consent exposure early and built the process into the deal timeline.

How the Consent Process Works

The consent process is not standardized across carriers. Every carrier has its own internal workflow, its own review criteria, and its own timeline. What you can generally expect:

Step 1: Identify which agreements require consent. Pull every carrier agreement you have. Read the assignment clause in each one. Some will require written consent. Some will terminate automatically upon change of control. Some will transfer to an affiliated entity without restriction. Know what you're dealing with before you disclose a sale.

Step 2: Engage carriers early — before close. The mistake sellers make is waiting until after LOI execution or late in due diligence to contact carriers. By that point, a close timeline is already set. Carrier review processes can take weeks to months depending on the carrier, the size of the transaction, and their internal review workload. Front-load this work.

Step 3: Submit a complete consent request package. Most carriers will want, at minimum: the buyer's producer license information and licensing history, E&O coverage documentation, the buyer's current carrier appointment portfolio, and some indication of financial stability. For PE-backed buyers or large consolidators, carriers may also want information about the acquiring entity's ownership structure.

Step 4: Track each carrier's response separately. Treat every carrier consent as an independent workflow item with its own owner, its own deadline, and its own escalation path. Lumping them together means problems stay invisible until they aren't.

Step 5: Negotiate consent timing into the purchase agreement. Your purchase agreement should specify what happens if one or more carriers deny consent or fail to respond by a defined date. Does the buyer have the right to walk? Does the price adjust? Does the closing extend? Define it before you need it.

What Carriers Are Actually Evaluating

Carriers are not just stamping paperwork. When they receive a consent request, they are evaluating whether the buyer is someone they want to do business with under their standards for agency appointments. That evaluation typically covers:

Licensing and E&O. The buyer must be properly licensed in all states where your book operates, with active lines of authority matching the products they'll be servicing. E&O coverage must meet the carrier's minimums. Missing licensing in even one state where you have policies can hold up the entire consent for that carrier.

Production history and agency profile. Carriers want to know whether the buyer has a track record of placing business. First-time buyers who have never held a direct appointment with a particular carrier may face a longer review or a conditional approval that requires them to meet production thresholds within a defined period.

Loss ratio and book quality. Your existing book's loss ratio with that carrier is part of the record the buyer inherits. If your loss ratio is below the carrier's appetite, the consent request may trigger a broader underwriting review of the transferred book. This can result in non-renewal of individual policies in the book — a risk the buyer needs to model before closing.

Ownership structure. PE-backed buyers, holding companies, and franchise models introduce complexity that some carriers handle differently. A carrier that has straightforward consent processes for owner-to-owner transfers may have a more involved review for an acquisition by a platform that is itself a portfolio company of a private equity fund.

Consent Denied: What Actually Happens

Carriers rarely issue a formal "denial" letter. More commonly, they simply don't respond within the expected window, or they raise conditions that are difficult to meet on a deal timeline. The practical outcome is the same: the appointment doesn't transfer, and the buyer cannot service those clients under that carrier.

What that means for the deal depends on what those appointments represent. If the carrier accounts for 40 percent of your commission revenue, a failure to obtain consent from that carrier is a material deal risk — one that a buyer will almost certainly reprice or walk from. If it's a minor appointment representing 3 percent of revenue, the buyer may proceed and simply let those policies migrate to a different carrier at renewal.

This is why the due diligence phase should include a systematic audit of every carrier appointment and its agreement terms — not just revenue concentration, but the terms under which those appointments can transfer. Buyers who skip this step are building their deal model on an assumption that may not hold.

Structuring the Deal to Manage Consent Risk

Sophisticated buyers and sellers build carrier consent mechanics directly into the purchase agreement. Here are the structures that come up most often in agency M&A transactions:

Contingency clause. The purchase agreement is conditioned on obtaining consent from identified carriers above a threshold — for example, carriers representing at least 80 percent of total commission revenue. If consent isn't obtained, the buyer can elect to walk without penalty.

Price adjustment mechanism. If a carrier representing a defined percentage of revenue fails to consent, the purchase price adjusts downward by a formula tied to that carrier's revenue contribution. The deal closes, but the buyer is compensated for the reduced book.

Extended close window. Rather than setting a fixed close date, the agreement sets a window — typically 60 to 120 days — during which consent can be obtained. This reduces the pressure that forces sellers to disclose the sale to carriers before they're ready.

Interim servicing arrangement. In some transactions, particularly in states where it's legally permissible, the parties use a management agreement or sub-producer arrangement to allow the buyer to operate the book under the seller's appointments during a transition period while formal consent is obtained. This is structurally complex and should involve legal counsel familiar with your state's insurance regulations.

Each of these has tradeoffs. Work through them with your M&A advisor before you settle on a structure. The letter of intent is where many of these mechanics are first outlined — by the time you're in a purchase agreement, the consent framework should already be agreed.

The Seller's Pre-Market Checklist

If you're preparing to sell in the next 12 to 24 months, these are the carrier consent questions to resolve before you go to market:

• Locate and read every current carrier agreement, specifically the assignment and termination clauses.
• Identify which carriers require written consent and which terminate automatically on change of control.
• Contact carriers you have a strong relationship with and confirm informally whether they have an established process for handling consent requests in acquisitions.
• Flag any carriers where your loss ratio or production volume might trigger additional scrutiny.
• Disclose this analysis to your M&A advisor before engaging buyers.

This is the same kind of preparation that separates deals that close from deals that die during due diligence. MarshBerry's analysis of insurance brokerage valuations consistently shows that top-performing sellers — those who prepare their carrier documentation, financials, and retention data before going to market — are the ones who command premium multiples and close on schedule. The sellers who scramble to get carrier consent after a buyer is engaged create uncertainty that discounts their deal, if it doesn't kill it outright.

OPTIS Partners' Tim Cunningham, commenting on the 2025 M&A market, said the environment "will continue to benefit the better sellers, whose valuations should remain at their current heady levels." Being a "better seller" in that framing is not about luck — it's about being the seller who has no avoidable surprises in due diligence.

The Buyer's Pre-LOI Checklist

If you're buying, here is what you need to know before you submit an offer:

• Request a list of all carrier appointments and review the assignment terms of each agreement during due diligence, not after LOI.
• Assess your own carrier appointment portfolio against the target agency's. For carriers where you don't have an existing relationship, model the timeline and risk of a new consent request.
• Price the deal with a carrier consent contingency so you have structured protection if key consents fail.
• Build consent timeline into your financing structure — a deal that needs 90 days for carrier consent on a 60-day close commitment has a mismatch that creates pressure on everyone.

The 695 agency transactions that closed in 2025 included buyers and sellers who treated carrier consent as a deal mechanic to be managed, not a formality to be assumed. The deals that fell apart or repriced mid-stream often had one thing in common: someone assumed consent was automatic.

It isn't.

---

Frequently Asked Questions

Q: Can a carrier refuse to give consent when I sell my agency?

A: Yes, if your agency agreement doesn't include a "not unreasonably withheld" standard, a carrier can deny consent without explanation. In practice, formal denials are less common than delays or conditional approvals, but the risk is real. The Big I/IIAT guide to agency agreements recommends negotiating this protection when you first sign carrier agreements — most agents don't read those terms until they're in a deal.

Q: What happens to my existing clients if a carrier doesn't consent?

A: The policies themselves don't disappear — they remain in force until renewal. But the buyer won't be able to service those clients under that carrier's appointment after close. At renewal, those clients may need to be remarketed to a different carrier. This is a real book-of-business risk that buyers should quantify before accepting.

Q: How long does carrier consent typically take?

A: It varies significantly by carrier. Some have streamlined processes and respond within weeks. Others have formal review committees that operate on quarterly cycles. For large transactions or PE-backed acquirers, the process can take longer. Plan for a range of several weeks to several months and structure your close timeline accordingly.

Q: Should I contact carriers before I have a buyer?

A: Not to disclose a sale, but yes to understand the process. Ask your carrier representatives whether they have a standard consent-request package and what their typical review timeline looks like. This intelligence is valuable before you set a close date with a buyer.

Q: Does carrier consent apply to stock sales as well as asset sales?

A: This depends on the specific language in each carrier agreement. Stock sales that transfer 100 percent of a corporation's equity — without changing the legal entity holding the appointment — may not trigger the assignment clause in some agreements. But many agreements define "change of control" broadly enough to include stock sales. Review each agreement carefully, and consult an insurance attorney in your state. Don't assume structure alone resolves the consent question.

---

Sources & References

1. OPTIS Partners — 2025 M&A Year-End Report
2. Insurance Journal — Pace of Insurance M&A Lagged in 2025 With No 'Mad Dash': OPTIS
3. IIAT (Big I Texas) — Guide to Agency-Company Agreements
4. MarshBerry — Insurance Brokerage M&A Stays Active in 2025 Amid Market Headwinds
5. MarshBerry — How to Think About Value
6. Big "I" / Reagan Consulting — 2025 Best Practices Study